{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:21:14Z","timestamp":1778620874837,"version":"3.51.4"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004863","name":"Zhejiang Chinese Medical University","doi-asserted-by":"publisher","award":["2017ZY08"],"award-info":[{"award-number":["2017ZY08"]}],"id":[{"id":"10.13039\/501100004863","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.intimp.2021.107574","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T12:49:43Z","timestamp":1617713383000},"page":"107574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Successful treatment of refractory cystitis associated with systemic lupus erythematosus with Belimumab"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3683-6056","authenticated-orcid":false,"given":"Liping","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinwei","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoding","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianrong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-an","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.intimp.2021.107574_b0005","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1177\/0961203315588575","article-title":"Lupus cystitis in Korean patients with systemic lupus erythematosus: risk factors and clinical outcomes","volume":"24","author":"Koh","year":"2015","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.intimp.2021.107574_b0010","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3899\/jrheum.100617","article-title":"Clinical features of lupus cystitis complicated with hydroureteronephrosis in a Chinese population","volume":"38","author":"Zhang","year":"2011","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107574_b0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1756287211398255","article-title":"Role of inflammation in bladder function and interstitial cystitis","volume":"3","author":"Grover","year":"2011","journal-title":"Ther. Adv. Urol."},{"issue":"5","key":"10.1016\/j.intimp.2021.107574_b0020","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1172\/JCI38010","article-title":"The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus","volume":"119","author":"Cancro","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.intimp.2021.107574_b0025","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3899\/jrheum.100617","article-title":"Clinical features of lupus cystitis complicated with hydroureteronephrosis in a Chinese population","volume":"38","author":"Zhang","year":"2011","journal-title":"J. Rheumatol."},{"issue":"27","key":"10.1016\/j.intimp.2021.107574_b0030","first-page":"213","article-title":"Relationship between T lymphocyte subsets and cortisol in systemic lupus erythematosus","volume":"7","author":"Shah","year":"2009","journal-title":"Kathmandu Univ. Med. J."},{"key":"10.1016\/j.intimp.2021.107574_b0035","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fphar.2019.00433","article-title":"Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients with Refractory Systemic Lupus Erythematosus Treated with Belimumab","volume":"10","author":"Regola","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107574_b0040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/clpt.2011.290","article-title":"Belimumab: a BLyS-specific inhibitor for the treatment of systemic lupus erythematosus","volume":"91","author":"Dennis","year":"2012","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921002101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921002101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:54:24Z","timestamp":1778619264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921002101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":8,"alternative-id":["S1567576921002101"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107574","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment of refractory cystitis associated with systemic lupus erythematosus with Belimumab","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107574"}}